Nephrology · Gadsden, AL
NPI
1063457539
Since 2006
Specialty
Nephrology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
427 S 3rd St
Gadsden, AL, 35901
Phone (256) 543-3508
Groups this clinician bills Medicare through
Medicare paid, 2024
$75K
618 services
Medicare patients, 2024
166
Average age 74
Drug cost, 2024
$1.1M
4,842 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Wan F Kwan was code 99213 (office e&m - established), 216 times for 84 patients. In total Wan F Kwan billed 618 services in 14 codes, and Medicare paid $75K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-01-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 216 | 84 | $59.49 | $13K |
| 90960 ESRD Related Services (not dialysis) | Office | 126 | 36 | $255.53 | $32K |
| 99232 Hospital E&M - Subsequent | Facility | 117 | 33 | $56.77 | $6,642 |
| 90961 ESRD Related Services (not dialysis) | Office | 74 | 24 | $213.41 | $16K |
| 99222 Hospital E&M - Initial | Facility | 24 | 22 | $94.08 | $2,258 |
By year: 2022 $172K for 1,660 services; 2023 $159K for 1,563 services; 2024 $75K for 618 services.
Medicare prescription drug claims, 2024
In 2024, the drug Wan F Kwan prescribed most often to Medicare patients was Carvedilol, with 391 prescriptions and refills. In total Wan F Kwan wrote 4,842 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carvedilol Generic | 391 | 1,043 | 122 | $3,604 |
| Rosuvastatin Calcium Generic | 362 | 978 | 121 | $8,640 |
| Losartan Potassium Generic | 340 | 848 | 107 | $4,820 |
| Amlodipine Besylate Generic | 262 | 711 | 90 | $2,039 |
| Jardiance Empagliflozin | 199 | 396 | 50 | $216K |
| Metformin Hcl Generic | 190 | 467 | 62 | $1,781 |
| Hydralazine Hcl Generic | 171 | 451 | 50 | $2,887 |
| Acarbose Generic | 168 | 426 | 65 | $9,115 |
| Pioglitazone Hcl Generic | 149 | 400 | 51 | $3,603 |
| Levothyroxine Sodium Generic | 139 | 388 | 45 | $2,293 |
| Farxiga Dapagliflozin Propanediol | 131 | 229 | 31 | $119K |
| Fenofibrate Generic | 129 | 302 | 33 | $2,959 |
| Entresto Sacubitril/Valsartan | 115 | 217 | 29 | $125K |
| Trulicity Dulaglutide | 110 | 177 | 29 | $173K |
| Ozempic Semaglutide | 107 | 168 | 29 | $153K |
Brand drugs: - claims; generic drugs: 3,893 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Wan F Kwan were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.